News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
883,761 Results
Type
Article (88774)
Company Profile (816)
Press Release (794149)
Multimedia
Podcasts (238)
Webinars (35)
Section
Business (233589)
Career Advice (4162)
Deals (39988)
Drug Delivery (177)
Drug Development (91701)
Employer Resources (207)
FDA (18553)
Job Trends (17486)
News (398727)
Policy (40013)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3053)
Academic (2)
Accelerated approval (56)
ADA (49)
Adcomms (40)
Allergies (196)
Alliances (56990)
ALS (236)
Alzheimer's disease (1967)
Antibody-drug conjugate (ADC) (551)
Approvals (18892)
Artificial intelligence (867)
ASCO (345)
Autoimmune disease (360)
Automation (64)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (248)
Biotechnology (480)
Bladder cancer (211)
Brain cancer (85)
Breast cancer (837)
Cancer (6563)
Cardiovascular disease (554)
Career advice (3597)
Career pathing (52)
CAR-T (384)
CDC (76)
Celiac Disease (3)
Cell therapy (1069)
Cervical cancer (54)
Clinical research (78984)
Collaboration (2365)
Company closure (8)
Compensation (1508)
Complete response letters (106)
COVID-19 (3041)
CRISPR (124)
C-suite (1282)
Cystic fibrosis (167)
Data (8668)
Decentralized trials (3)
Denatured (91)
Depression (193)
Dermatology (96)
Diabetes (703)
Diagnostics (7595)
Digital health (69)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (424)
Drug pricing (245)
Drug shortages (39)
Duchenne muscular dystrophy (318)
Earnings (102482)
Editorial (78)
Employer branding (25)
Employer resources (174)
Events (138637)
Executive appointments (1192)
FDA (22615)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (19)
Frontotemporal dementia (36)
Funding (1938)
Gene editing (270)
Generative AI (89)
Gene therapy (849)
GLP-1 (1284)
Government (5559)
Grass and pollen (8)
Guidances (419)
Healthcare (21259)
Hematology (198)
HIV (94)
Huntington's disease (64)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (352)
Immuno-oncology (116)
Indications (206)
Infectious disease (3438)
Inflammatory bowel disease (242)
Inflation Reduction Act (17)
Influenza (148)
Intellectual property (322)
Interviews (821)
IPO (18001)
IRA (61)
Job creations (5209)
Job search strategy (2871)
JPM (73)
Kidney cancer (23)
Labor market (122)
Layoffs (686)
Leadership (53)
Legal (10171)
Liver cancer (111)
Longevity (37)
Lung cancer (873)
Lymphoma (464)
Machine learning (66)
Management (66)
Manufacturing (1220)
MASH (226)
Medical device (15276)
Medtech (15433)
Mergers & acquisitions (23285)
Metabolic disorders (1820)
mRNA (266)
Multiple sclerosis (204)
NASH (24)
Neurodegenerative disease (506)
Neuropsychiatric disorders (126)
Neuroscience (3711)
Neurotech (2)
NextGen: Class of 2026 (7715)
Non-profit (5145)
Now hiring (80)
Obesity (869)
Opinion (374)
Ovarian cancer (244)
Pain (284)
Pancreatic cancer (350)
Parkinson's disease (416)
Partnered (39)
Patents (653)
Patient recruitment (757)
Peanut (70)
People (67990)
Pharmaceutical (136)
Pharmacy benefit managers (37)
Phase 1 (24410)
Phase 2 (34305)
Phase 3 (25800)
Pipeline (9726)
Policy (397)
Postmarket research (3559)
Preclinical (10978)
Press Release (72)
Prostate cancer (347)
Psychedelics (68)
Radiopharmaceuticals (373)
Rare diseases (1261)
Real estate (7462)
Recruiting (81)
Regulatory (30379)
Reports (77)
Research institute (2771)
Resumes & cover letters (654)
Rett syndrome (42)
RNA editing (29)
RSV (98)
Schizophrenia (196)
Series A (327)
Series B (237)
Service/supplier (28)
Sickle cell disease (127)
Special edition (32)
Spinal muscular atrophy (190)
Sponsored (55)
Startups (4371)
State (2)
Stomach cancer (21)
Supply chain (146)
Tariffs (104)
The Weekly (144)
Vaccines (1306)
Venture capital (133)
Weight loss (597)
Women's health (141)
Worklife (24)
Date
Today (133)
Last 7 days (670)
Last 30 days (3306)
Last 365 days (33272)
2026 (16124)
2025 (33218)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1296)
Alabama (102)
Alaska (7)
Arizona (402)
Arkansas (16)
Asia (52290)
Australia (9192)
California (14359)
Canada (4009)
China (1570)
Colorado (618)
Connecticut (639)
Delaware (443)
Europe (120589)
Florida (2129)
Georgia (467)
Hawaii (4)
Idaho (70)
Illinois (1249)
India (102)
Indiana (663)
Iowa (25)
Japan (590)
Kansas (143)
Kentucky (56)
Louisiana (64)
Maine (89)
Maryland (1740)
Massachusetts (10505)
Michigan (422)
Minnesota (799)
Mississippi (7)
Missouri (164)
Montana (37)
Nebraska (30)
Nevada (153)
New Hampshire (92)
New Jersey (3807)
New Mexico (35)
New York (3775)
North Carolina (1937)
North Dakota (11)
Northern California (7138)
Ohio (449)
Oklahoma (27)
Oregon (55)
Pennsylvania (2829)
Puerto Rico (30)
Rhode Island (54)
South America (1668)
South Carolina (88)
South Dakota (2)
Southern California (5632)
Tennessee (227)
Texas (2339)
United States (51375)
Utah (426)
Vermont (1)
Virginia (363)
Washington D.C. (89)
Washington State (1179)
West Virginia (4)
Wisconsin (160)
Wyoming (2)
There are 883,761 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
C4 Therapeutics Presents Phase 1 Data at European Hematology Association (EHA) 2026 Congress Highlighting Cemsidomide as a Potential Best-in-Class IKZF1/3 Degrader for Multiple Myeloma in Heavily Pretreated Relapsed/Refractory Population
June 11, 2026
·
10 min read
Press Releases
Neion Bio Raises Oversubscribed $23 Million Series A to Advance Biologics Manufacturing Platform and Expand Pipeline
June 11, 2026
·
4 min read
Press Releases
BlossomHill Therapeutics Presents Initial Clinical Data from Dose Escalation in Ongoing Phase 1/1b Trial of Novel Macrocyclic CLK Inhibitor, BH-30236, in Patients with R/R AML or HR-MDS at EHA 2026
June 11, 2026
·
5 min read
Press Releases
Syndax Showcases Revuforj® (revumenib) Clinical Activity in Multiple Acute Leukemia Subtypes and Settings at EHA 2026
June 11, 2026
·
16 min read
Funding
SonoThera bags $125M series B to advance safer gene therapies
Instead of using viral vectors, SonoThera’s genetic medicines are delivered through an ultrasound-mediated technology that could help sidestep key safety issues with conventional delivery methods.
June 11, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Stallergenes Greer Will Present New Evidence on Long-term Outcomes in Allergen Immunotherapy at EAACI 2026
June 11, 2026
·
4 min read
Press Releases
Anocca has Dosed First Patients with Precision TCR-T Cell Therapy Targeting Mutant KRAS in Pancreatic Cancer
June 11, 2026
·
4 min read
Press Releases
Vertex Presents New Data on CASGEVY®, Including First European Presentation of Data in Children Ages 5–11, at the European Hematology Association Congress and Announces Additional Global Regulatory Submissions
June 11, 2026
·
15 min read
Deals
Novartis tightens bond with Orionis in up to $1.4B molecular glue deal
It’s the latest Big Pharma deal for molecular glue technology and Novartis’ second with Orionis Biosciences, after first linking up in March 2020. The backloaded agreement will see Novartis pay $40 million upfront.
June 11, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Peer-reviewed publication shows that Lateral pharma’s SCP drugs for neuropathic pain act via the novel target LanCL1
June 11, 2026
·
3 min read
1 of 88,377
Next
